External Counterpulsation Therapy (also called ECP or EECP) has been reclassified as a Class II product by the Food & Drug Administration for severe Angina not amendable to surgery.  This comes as big news to the External Counterpulsation Therapy industry as the ECP and EECP devices have been categorized as a Class III device. The […]

Read more